Literature DB >> 8387384

Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

H Moritoki1, H Miyano, S Takeuchi, M Yamaguchi, T Hisayama, W Kondoh.   

Abstract

1. Endothelin-3 (ET-3) at concentrations below those which caused contraction (30 nM) elicited endothelium-dependent relaxation followed by rebound contraction in rat isolated thoracic aorta. 2. Endothelin-1 also relaxed the rat aorta with a similar potency. 3. The nitric oxide (NO) synthase inhibitor, NG-nitro L-arginine, the radical scavenger, haemoglobin and the soluble guanylate cyclase inhibitor, methylene blue, each inhibited the ET-3-induced relaxation. 4. The calmodulin inhibitor, calmidazolium, considerably attenuated the relaxation caused by ET-3 without affecting that to nitroprusside. 5. Concentrations of ET-3 that were necessary to induce the relaxation also caused concentration-dependent elevation of guanosine 3':5'-cyclic monophosphate (cyclic GMP) levels. 6. NG-nitro L-arginine, haemoglobin, methylene blue, calmidazolium and removal of the endothelium completely abolished ET-3-stimulated cyclic GMP production. 7. These results suggest that ET-3 triggers NO formation possibly via ETB receptors on the endothelium to activate soluble guanylate cyclase, which in turn stimulates cyclic GMP production and smooth muscle relaxation. The enzyme contributing to the NO formation may be of the calcium/calmodulin-dependent, constitutive type.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387384      PMCID: PMC1908164          DOI: 10.1111/j.1476-5381.1993.tb13515.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

2.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

3.  An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

Authors:  M Honma; T Satoh; J Takezawa; M Ui
Journal:  Biochem Med       Date:  1977-12

4.  Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration.

Authors:  A C Le Monnier de Gouville; H Lippton; G Cohen; I Cavero; A Hyman
Journal:  J Pharmacol Exp Ther       Date:  1990-09       Impact factor: 4.030

5.  Modulation by endothelium of the responses induced by endothelin-1 and by some of its analogues in rat isolated aorta.

Authors:  S Topouzis; J P Huggins; J T Pelton; R C Miller
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

6.  Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin.

Authors:  R Busse; A Mülsch
Journal:  FEBS Lett       Date:  1990-06-04       Impact factor: 4.124

7.  Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.

Authors:  U Förstermann; J S Pollock; H H Schmidt; M Heller; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

8.  Histamine potentiation of nerve- and drug-induced responses of a rabbit cerebral artery.

Authors:  J A Bevan; S P Duckles; T J Lee
Journal:  Circ Res       Date:  1975-05       Impact factor: 17.367

9.  Endothelin-3 stimulates production of endothelium-derived nitric oxide via phosphoinositide breakdown.

Authors:  T Emori; Y Hirata; K Kanno; K Ohta; S Eguchi; T Imai; M Shichiri; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

10.  Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery.

Authors:  S Illiano; T Nagao; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more
  5 in total

Review 1.  Endothelin receptor heterogeneity, G-proteins, and signaling via cAMP and cGMP cascades.

Authors:  M Sokolovsky
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

2.  ETB-type receptors mediate endothelin-stimulated contraction in the aortic vascular smooth muscle of the spiny dogfish shark, Squalus acanthias.

Authors:  D H Evans; M Gunderson; C Cegelis
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

3.  Role of endothelin type B receptor in NO/cGMP signaling pathway in rat median eminence.

Authors:  Yaira Mathison; Anita Israel
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

4.  Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

Authors:  B Hocher; C Thöne-Reineke; P Rohmeiss; F Schmager; T Slowinski; V Burst; F Siegmund; T Quertermous; C Bauer; H H Neumayer; W D Schleuning; F Theuring
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  Endothelin signaling pathways in rat adrenal medulla.

Authors:  Israel Anita; Mathison Yaira; Garrido María del Rosario
Journal:  Cell Mol Neurobiol       Date:  2006-08-09       Impact factor: 5.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.